Revenues increase 18%; Net income increases 366% Leatt Corporation (OTCQB: LEAT), a leading developer and marketer of head-to-toe protective equipment for Moto, MTB, ADV and a wide range of extreme and high-velocity sports, today announced financial results for the third quarter ending September 30, 2025. All financial numbers are in U.S. dollars. Third Quarter and […]
WINSTON-SALEM, NC / ACCESS Newswire / November 6, 2025 / C-store retailers seeking greater stability and durability in their gravity-fed cooler shelving have a new option in Planniq Chill™ from ImageWorks Display®. Planniq Chill combines the labor-saving, customer-friendly elements of gravity-fed shelving with ImageWorks Display’s signature high build quality and durability. "Planniq Chill is a
MIAMI BEACH, FL / ACCESS Newswire / November 6, 2025 / C2 Blockchain Inc. (OTCID:CBLO), a digital asset treasury and blockchain infrastructure company, today announced that it has expanded its holdings of DOG, a leading Rune token built directly on the Bitcoin blockchain, from 524,514,226 DOG to 549,784,364 DOG. This increase underscores C2 Blockchain’s strategic
The acquisition brings Paylode's industry-leading perks and rewards platform, ancillary revenue technology, and extensive partnerships ecosystem to the Moved platform-catalyzing growth, engagement, and retention for residential real estate operators. Moved, the leading proptech platform for automating resident moves and ancillary revenue, today announced the acquisition of Paylode, a perks-and-partnerships technology platform that enables companies to
Helping enterprises close the AI trust gap through identity-first accountability. Ping Identity, a leader in securing digital identities for the world's largest enterprises, today announced “Identity for AI,” a new solution designed to secure and enable the rapidly evolving world of AI agents. https://mma.prnewswire.com/media/1720866/Ping_Logo.jpg As organizations embrace agentic AI to boost productivity and commerce, Ping
Recognizing exceptional leadership in patient education and clinical skill in the GammaTile procedure GT Medical Technologies, a medical device company dedicated to improving the lives of patients with brain tumors, today announced Banner University Medical Center Tucson as the latest GammaTile®Center of Excellence Program designation. https://mma.prnewswire.com/media/1751873/GT_Medical_Technologies_Logo.jpg The program recognizes leaders in patient care dedicated to
Air Pollution Linked to Early Alzheimer's Risk, Even in Children A new peer-reviewed article published in the Journal of Alzheimer's Disease, by the Alzheimer's Research and Prevention Foundation, reveals compelling evidence that air pollution and climate stress are major (modifiable) risk factors for Alzheimer's disease, and introduces a revolutionary prevention plan grounded in evidence based
Pivotal GRAND CANYON cohort of sevasemten in Becker expected to read out in Q4 2026; building infrastructure to support potential commercial launch – MESA open-label extension trial of sevasemten in Becker muscular dystrophy continues to enroll nearly all eligible participants – Continuing to advance Phase 2 CIRRUS-HCM trial of EDG-7500 in Hypertrophic Cardiomyopathy; on track
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the third quarter endedSeptember 30, 2025and provided a corporate update. https://mma.prnewswire.com/media/627654/Lipocine_Logo.jpg Neuroactive Steroids (NAS) LPCN 1154 for Postpartum Depression (PPD) — LPCN 1154 (oral brexanolone) is a non-invasive, rapid onset, oral
Zoomd Technologies Ltd.(TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, “Zoomd” or the “Company”), the marketing technology (MarTech) user-acquisition and engagement platform, announced its participation as a Silver Sponsor at Business of Apps Berlin 2025 (formerly App Promotion Summit), taking place on November 27, 2025, at the Hotel Adlon Kempinski in Berlin,